US FDA conducts inspection at Alkem Labs Taloja facility

Alkem Laboratories Ltd has announced that the US Food and Drug Administration (FDA) had conducted an inspection at the company's bioequivalence center located at Taloja, Maharashtra from 14th October, 2019 to 18th October, 2019.

At the end of the inspection, no Form 483 was issued, the company said.

Comments

Popular posts from this blog

Updated Ph. Eur. Chapter on plastic containers

Dr. Stephen Hahn Nominated to Head FDA